Generare
Generates molecular data for drug development
€20MSeries A
Role not disclosedA
Alven
Activity from announced rounds
Activity in this selectionSeries A
Alven is an investment firm whose own news covers Archy’s Series C and which Attention identifies as a returning investor.
Recorded funding activity
Archy combines dental-practice operations and clinical software with AI tools for routine administrative work. Attention develops agents for revenue-team workflows. The recorded history also includes Generare, which produces molecular data for drug development. These company-level events connect Alven’s attribution across distinct business applications.
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $85.7M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionKestra
Provides open-source orchestration platform unifying data, AI, infrastructure and business workflows
$25MSeries A
Role not disclosedVerley
Develops functional whey protein ingredients through precision fermentation for food and nutrition manufacturers
€32MSeries A
Role not disclosed